Item 2.02 Results of Operations and Financial Condition.

The information set forth in Item 7.01 is hereby incorporated by reference into this Item 2.02.

Item 7.01 Regulation FD Disclosure.

On January 11, 2021, ORIC Pharmaceuticals, Inc. (the "Company") issued a press release announcing a corporate update, expected milestones for 2021 and the Company's participation in the JP Morgan Healthcare Conference.

A copy of the press release is attached hereto as Exhibit 99.1 and a copy of the Company's current corporate presentation is attached hereto as Exhibit 99.2, which are incorporated herein by reference.

All of the information furnished in this Item 7.01 and Items 2.02 and 9.01 (including Exhibits 99.1 and 99.2) shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits



             Exhibit
               No.     Description

             99.1        Press Release dated January 11, 2021

             99.2        Corporate Presentation dated January 2021




                                      -2-

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses